Featured Stock Overview: Johnson & Johnson (NYSE:JNJ)

7

Johnson & Johnson (NYSE:JNJ) currently has a “Buy” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Buy” signal. 10 – 8 Day Moving Average Hilo Channel shows “Buy” signal. While 20-Day Moving Average VS Current Price shows “Buy” Signal.

Johnson & Johnson (NYSE:JNJ) gained 1.2 Percent and closed its previous trading session at $127.76. The stock traded with the average Volume of 6.52 Million at the end of last session.

Johnson & Johnson (NYSE:JNJ) has the Market Capitalization of 342.68 Billion. The Stock has its 52-week High of $148.32 and 52-Week Low of $118.62 and it touched its 52-week high on 01/17/18 and 52-Week Low on 05/29/18

.

The company reported its last earnings Actual EPS of $2.06/share. While, the analyst predicted that the company could provide an EPS of $2.02/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.04/share which shows an Earnings Surprise of 2 Percent.

Sell side analysts plays vital role in buying and selling a stock where 5 analysts rated Johnson & Johnson (NYSE:JNJ) as Buy, 1 analysts given Outperform signal, 2 reported Hold, and 0 analysts rated the stock as Sell.

The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 3.77% where SMA50 and SMA200 are 3.7% and -3.69% respectively.

The company shows its Return on Assets (ROA) value of 0.8%. The Return on Equity (ROE) value stands at 1.8%. While it’s Return on Investment (ROI) value is 15.7%.

Johnson & Johnson (NYSE:JNJ) currently has a Weekly Volatility of 1.00% percent while its Monthly Volatility is at 1.26% percent. While talking about Performance of the Stock, Johnson & Johnson currently has a Weekly performance of 2.21%, monthly performance percentage is 4.26 percent, Quarterly performance is -2.05 percent, 6 months performance shows a percent value of -11.26% and Yearly Performance is -3.38 percent.

Company Profile:

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women’s health fields, nutritional and over-the-counter pharmaceutical products. The company’s Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women’s health products. Johnson & Johnson is based in New Brunswick, New Jersey.

SHARE